EnBiotix Inc.
Harnessing systems and synthetic biology to battle bacterial infections
This article was originally published in Start Up
Executive Summary
EnBiotix Inc. is focused on two anti-infective platforms: one an approach to revitalizing existing antibiotics, and the second a means of empowering phages, viruses that are natural enemies of bacteria. There is successful scientific precedence for both platforms, which stand to get a boost from network biology.